Fighting Irish add explosive playmaker Mylan Graham. The talented wide receiver leaves Ohio State, bringing game-changing speed and route-running polish to South Bend.
While Mylan agreed to settle its Medicaid rebate case with the federal government last week for $465 million, the drugmaker is not required to classify EpiPens as a branded drug under Medicaid’s ...
Mylan Graham, the former New Haven standout wide receiver who was the No. 1 recruit from Indiana in the '24 class, will ...
Mylan’s $465 million proposed settlement with CMS may not cover the amount of money it allegedly saved by improperly classifying EpiPens as a generic drug, according to research published Monday in ...
In a congressional hearing last week, Mylan chief executive Heather Bresch did not give an accurate number concerning how much the company made from a two-pack of EpiPens, according to The Washington ...
The Nebraska Cornhuskers are undergoing a mini rebuild following the 2024 season. Starting quarterback Dylan Raiola entered the transfer portal, and numerous solid rotational pieces have followed suit ...
(Reuters) - Mylan NV, which has come under fire for its drug pricing, said on Friday it would start selling a generic version of its life-saving EpiPen allergy treatment for $300 per two-pack, a more ...
(Reuters) - U.S. regulators said on Wednesday that Mylan NV's EpiPen products are in shortage due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy ...
As we have previously reported, Regeneron’s BPCIA case against Mylan regarding Mylan’s proposed aflibercept biosimilar is proceeding on an expedited schedule, with a two-week trial scheduled to begin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results